US 7,592,339 B2
Substituted oxazolidinones and their use in the field of blood coagulation
Alexander Straub, Wuppertal (Germany); Thomas Lampe, Wuppertal (Germany); Jens Pohlmann, Wuppertal (Germany); Susanne Rohrig, Essen (Germany); Elisabeth Perzborn, Wuppertal (Germany); Karl-Heinz Schlemmer, Wuppertal (Germany); and Joseph Pernerstorfer, Wuppertal (Germany)
Assigned to Bayer Schering Pharma Aktiengesellschaft, Berlin (Germany)
Filed on Jul. 27, 2006, as Appl. No. 11/460,529.
Application 11/460529 is a division of application No. 10/181051, granted, now 7,157,456, filed on Jan. 02, 2007, previously published as PCT/EP00/12492, filed on Dec. 11, 2002.
Prior Publication US 2006/0258724 A1, Nov. 16, 2006
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/5377 (2006.01); C07D 409/14 (2006.01)
U.S. Cl. 514—236.8  [544/139] 21 Claims
 
1. A method for inhibiting thrombus formation comprising administering an effective amount of a compound of formula:

OG Complex Work Unit Drawing
or a hydrate thereof, to a patient in need of said method.